Turning Point Therapeutics Shares Surge on Bristol Myers Deal morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
The agent is Turning Point's first in-licensed product, which is currently undergoing early-stage trials in Claudin18.2-positive advanced solid tumors.